What is NextPharma?
NextPharma, established in 2000 and headquartered in London, is a pharmaceutical contract development and manufacturing organization. The company offers a comprehensive suite of services, including pharmaceutical development, manufacturing and packaging, clinical trials, and analytical and microbiological solutions. Its position in the market is defined by its end-to-end capabilities in supporting drug lifecycle management.
How much funding has NextPharma raised?
NextPharma has raised a total of $30.5M across 1 funding round:
Debt
$30.5M
Debt (2007): $30.5M, investors not publicly disclosed
What's next for NextPharma?
The substantial enterprise-level funding and recent strategic investment indicate a phase of significant scaling and potential expansion for NextPharma. This capital infusion is likely to fuel advancements in their service offerings, potentially broadening their manufacturing capacity, enhancing their R&D capabilities, or expanding their geographical reach. The company is poised to leverage this backing to solidify its role as a key player in the pharmaceutical contract services sector.
See full NextPharma company page